| Financial Year |
March 31 2022 |
| Monetary Funds |
8,707,497.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
64,267,009.33 |
| Advances to Suppliers |
2,154,245.11 |
| Other Receivables |
26,382,709.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,919,877.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,479,626.14 |
| Total Current Assets |
115,910,965.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,929,413.88 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,666.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
98,555.50 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
5,255,731.08 |
| Total Assets |
121,166,697.01 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
22,827,107.67 |
| Accounts Received In Advance |
1,804,223.72 |
| Employee Compensation Payable |
922,314.58 |
| Taxes Payable |
908,925.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,418,919.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
40,881,490.52 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
64,776,673.51 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
64,776,673.51 |
| Total Liabilities |
105,658,164.03 |
| Paid-In Capital(Or Share Stock) |
160,000,000.00 |
| Capital Surplus |
223,153,621.21 |
| Surplus Reserve |
11,251,633.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-376,541,529.68 |
| Minority Stockholder's Interest |
-2,355,191.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,863,724.74 |
| Owner's Equity（Stockholder's Equity） |
15,508,532.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
121,166,697.01 |
